An LP-01-based LNP solution for expressing GFP
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

LipidLaunch™ LP-01 LNP (GFP)

Item No. 40100

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Synonyms
  • LipidLaunch™ CIN-16645 LNP (GFP)
Emission
507 nm
Excitation
488 nm
Formulation (Request formulation change)
TBS, pH 7.5, with 10% sucrose
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 µg

    $395

    Add
    Cayman Chemical
    Product Description

    LipidLaunch™ LP-01 LNP (GFP) is a solution containing lipid nanoparticles (LNPs) composed of the ionizable cationic amino lipid LP-01 (Item No. 37278), cholesterol (Item No. 9003100), 1,2-distearoyl-sn-glycero-3-PC (DSPC; Item No. 15100), and the lipid excipient DMG-PEG(2000) (Item No. 33945) at a molar ratio of 45:44:9:2 and encapsulating mRNA encoding the fluorescent protein GFP. It is intended for proof-of-concept experiments to determine whether LP-01-based LNPs can effectively lead to the expression of a protein of interest in a target cell type, either in vitro or in vivo. GFP displays excitation/emission maxima of 488/507 nm, respectively.

    Suggested in vitro use: Thaw LNPs on ice with occasional gentle swirling (do not vortex). Using a gentle pipetting technique, dilute 1:100-1:500 in complete cell culture media (with serum) and add to subconfluent adherent cells in a fluorescence imaging-compatible tissue culture plate. Expression of GFP may be detectable as early as six hours after treatment. Optimal conditions are highly dependent on cell type.

    WARNING This product is not for human or veterinary use.